Grant RadarWorldwide funding

Browse grants Log in Get started

Health Opening SoonRFA-HG-26-002

Genomic Community Resources (U24 Clinical Trials Not Allowed)

National Institutes of Health opportunity RFA-HG-26-002

Eligible Applicants

Organization Types

UniversitiesNGOsSMEsGovernment Agencies

Eligible Countries / Regions

United States

Keywords

National Institutes of HealthRFA-HG-26-002Grants.gov

Related Grants

Specialized Center Cooperative Agreements in Aging and/or Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Research

Amount not stated

CONTAMINATED ALASKA NATIVE CLAIMS SETTLEMENT ACT LANDS ASSISTANCE PROGRAM

Amount not stated

31 Dec 2027(420d)

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Require

Amount not stated

19 Nov 2026(13d)

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Amount not stated

23 Dec 2027(412d)

Funding Amount

Amount not stated

USD

The funder has not published an amount yet — check the call documents.

Programme Details

Programme Code

RFA-HG-26-002